−3.20SEK
−109.29 MSEK
21.92 M
About ASCELIA PHARMA AB
Sector
CEO
Magnus Olafsson Corfitzen
Headquarters
Malmö
Website
Employees (FY)
13
Founded
1999
ISIN
SE0010573113
FIGI
BBG00NF05BL9
Ascelia Pharma AB engages in the research and development of pharmaceutical products for the treatment of cancer and cancer-related diseases. It offers the following clinical stage product candidates: Mangoral, a liver imaging drug being developed for detection and localization of potential liver metastases; and Oncoral, a tablet-based formulation of the chemotherapeutic agent irinotecan, intended for the treatment of advanced gastric cancer. The company was founded on May 17, 1999, and is headquartered in Malmö, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ACE is 13.88 SEK — it has decreased by 0.14% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ASCELIA PHARMA AB stocks are traded under the ticker ACE.
ASCELIA PHARMA AB is going to release the next earnings report on May 16, 2024. Keep track of upcoming events with our Earnings Calendar.
ACE stock is 9.83% volatile and has beta coefficient of 2.22. Check out the list of the most volatile stocks — is ASCELIA PHARMA AB there?
One year price forecast for ASCELIA PHARMA AB has a max estimate of 12.00 SEK and a min estimate of 12.00 SEK.
ACE earnings for the last quarter are −1.20 SEK whereas the estimation was −0.90 SEK which accounts for −33.33% surprise. Estimated earnings for the next quarter are −0.90 SEK. See more details about ASCELIA PHARMA AB earnings.
Yes, you can track ASCELIA PHARMA AB financials in yearly and quarterly reports right on TradingView.
ACE stock has risen by 24.60% compared to the previous week, the month change is a 55.08% rise, over the last year ASCELIA PHARMA AB has showed a 2.80% decrease.
ACE net income for the last quarter is −10.60 M SEK, while the quarter before that showed −21.22 M SEK of net income which accounts for 50.05% change. Track more ASCELIA PHARMA AB financial stats to get the full picture.
Today ASCELIA PHARMA AB has the market capitalization of 469.23 M, it has increased by 5.24% over the last week.
No, ACE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ACE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASCELIA PHARMA AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 13.00 employees. See our rating of the largest employees — is ASCELIA PHARMA AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ASCELIA PHARMA AB technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ASCELIA PHARMA AB stock shows the buy signal. See more of ASCELIA PHARMA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ASCELIA PHARMA AB future price: according to them, ACE price has a max estimate of 12.00 SEK and a min estimate of 12.00 SEK. Read a more detailed ASCELIA PHARMA AB forecast: see what analysts think of ASCELIA PHARMA AB and suggest that you do with its stocks.